Long-term Open-label Treatment of Moderate to Severe Glabellar Lines With CORETOX®
NCT04281745
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
BIOLOGICAL:
CORETOX Inj
Sponsor
Medy-Tox